The Lip Service Problem In 25+ years of working with biotech leadership teams, I’ve heard countless executives assure investors,...

As a professional whose career started in the 1980s, AI feels like the early days of PCs, the Internet, and smartphones—big hype, real...

At DHL, we are committed to finding ways to use AI to help us do our patent tasks more efficiently and more effectively. We use AI every...

Why Your Biotech Patent Keeps Getting Rejected, and What to Do About It. If your biotech patent application keeps getting rejected, it’s...

(Check out the short version of this post, if you don't want all the details in this patent professional version.) Introduction: It can...

SUMMARY   In this post we present a prioritization matrix tool that enables your IP team to dedicate an appropriate amount of resources...

Biotech products and processes evolve over time. This can cause a misalignment between your issued/pending patent claims, and your...

Biotech innovation is regularly faced with a thicket of prior art that applicants must navigate during patent prosecution. Examiners at...

SUMMARY: Biologic candidates evolve during clinical trials - so should your patents. Updated filings before public trial disclosures...

Too many biotech companies treat IP like a checkbox. Smart ones prune ruthlessly—and build value, not just volume: Prune entire families...

INTRODUCTION Executives usually ask these quantitative but high-level questions: How much money did we spend on patent work this year?...

As a biotech company, much of your value is in (pre-revenue) and/or protected by (post-revenue) your intellectual property. As you...

INTRODUCTORY COMMENTS RE: BIOTECH/PHARMA EXTENDED PATENT FAMILIES In complex art areas like biotech/biopharma, patent strategy is about...

It's that time of year again... Annual patent planning for your company/client(s) for next year. Here are some key dates to track as you...